Ann Padilla, MD
Family Medicine · Gilbert, AZNPI 1790705598
Payments from drug & device makers
Across 196 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$863
- Astellas Pharma US Inc$315
- Lilly USA, LLC$312
- Pfizer$235
- AstraZeneca$230
- Dexcom, Inc.$130
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,23795%
- Education$1555%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $863 |
| Astellas Pharma US Inc | 10 | $315 |
| Lilly USA, LLC | 19 | $312 |
| Pfizer | 14 | $235 |
| AstraZeneca | 14 | $230 |
| Dexcom, Inc. | 6 | $130 |
| Merck | 6 | $115 |
| Amgen | 6 | $106 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $84 |
| GSK | 5 | $83 |
| Radius Health, Inc. | 3 | $82 |
| Novo Nordisk | 5 | $72 |
| Currax Pharmaceuticals LLC | 5 | $71 |
| Gilead | 2 | $51 |
| Boehringer Ingelheim | 3 | $50 |
| Novartis | 3 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $49 |
| Johnson & Johnson | 4 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Topcon Healthcare Solutions, Inc. | 1 | $37 |
| Boston Scientific | 2 | $34 |
| Impulse Dynamics (USA) Inc. | 2 | $32 |
| Bayer | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Medtronic(2 entities) | 2 | $30 |
| Exact Sciences | 2 | $29 |
| VBI Vaccine (delaware) Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Photonicare Inc | 1 | $20 |
| Teleflex LLC | 1 | $19 |
| Biotronik NRO, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
How this compares
$3,392 in reported general payments places this provider in the 85th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 119 | $148,049 |
| JardianceEmpagliflozin | 146 | $134,644 |
| TrulicityDulaglutide | 62 | $80,045 |
| EliquisApixaban | 77 | $77,248 |
| MounjaroTirzepatide | 49 | $66,770 |
| ProliaDenosumab | 37 | $63,493 |
| JanumetSitagliptin Phos/Metformin Hcl | 32 | $41,166 |
| LinzessLinaclotide | 39 | $28,552 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 50 | $27,766 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 24 | $18,253 |
| MyrbetriqMirabegron | 19 | $16,584 |
| Breo ElliptaFluticasone/Vilanterol | 28 | $14,354 |
| RybelsusSemaglutide | 12 | $11,290 |
| Levothyroxine Sodium | 1,057 | $10,934 |
| NexletolBempedoic Acid | 12 | $8,035 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $72 | $159,339131 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $312 | $146,815111 claims |
| Boehringer IngelheimJardiance | $50 | $134,644146 claims |
| PfizerEliquis | $235 | $77,24877 claims |
| AmgenProlia | $106 | $63,49337 claims |
| GSKAnoro Ellipta, Breo Ellipta | $83 | $42,12078 claims |
| MerckJanumet | $115 | $41,16632 claims |
| AbbVieLinzess, Synthroid | $863 | $33,777127 claims |
| Astellas Pharma US IncMyrbetriq | $315 | $16,58419 claims |
| AstraZenecaSymbicort | $230 | $5,80011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Gilbert
- Sunildat MaheshwariGilbert$2M
- Lawrence FeldGilbert$382K
- Danielle ArmasScottsdale$73M
- Terry O'ReillyMesa$35.8M
- Shawn SearleChandler$27M
- Corey AndersonMesa$21.5M
- Dena PetersenTucson$14.7M
- Gerald ShockeyMesa$12.3M
- Brock MerrittPhoenix$8.4M
- John McGettiganTucson$8.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.